C2i Genomics
C2i Genomics

C2i Genomics

DR64Ahrefs DR: 64/100. Above median. Measured by Ahrefs. Median 44.Agent30Agent Readiness: 30/100. Below median. Measured by StartupHub.ai. Median 41.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Website
2018Active17Tel Aviv, Israel

About

C2i Genomics is pioneering the most comprehensive whole-genome monitoring for cancer recurrence and progression. Their technology analyzes subtle changes in the tumor's DNA patterns to provide early detection and personalized treatment monitoring.

Key facts

At-a-glance profile data

Website
veracyte.com
Headquarters
Tel Aviv, Israel
Founded
2018
Employees
17
Total funding
$112M (Series B)
Business model
B2B

Funding rounds

Funding rounds raised by C2i Genomics
DateRoundAmountLead investors
18 Apr 2021Series B$100M-
10 Jun 2020Series A$12M-
1 May 2020GrantUndisclosed-
1 Sept 2018SeedUndisclosed-

Tech stack

Detected on veracyte.com, last scanned 25 Sept 2026. Run your own scan

Frontend
jQuery, Bootstrap
Analytics
Google Analytics 4, Google Tag Manager
SEO
Yoast SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Mimecast
Video / media
Vimeo
Add first review

Frequently asked

How much funding has C2i Genomics raised?

C2i Genomics has raised a total of $112M in funding. The most recent round on record is Series B.

How many employees does C2i Genomics have?

C2i Genomics has approximately 17 people on record.